HIGHLIGHTS
- who: Kun Zuo and Lefeng Wang from the Peking University, China have published the article: Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis, in the Journal: (JOURNAL) of June/01,/2021
- what: This study was designed to evaluate the plasma levels of Phe and its downstream metabolites and their potential relationships with coronary ISR. This study provides a promising target for preventing and treating coronary ISR from the perspective of dietary and GM regulation. Prospective studies validating the discriminatory ability of PAGln to predict ISR and studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.